{"id":"https://openalex.org/W2018147385","doi":"https://doi.org/10.1007/s00280-014-2560-3","title":"Population pharmacokinetic and covariate analysis of pertuzumab, a HER2-targeted monoclonal antibody, and evaluation of a fixed, non-weight-based dose in patients with a variety of solid tumors","display_name":"Population pharmacokinetic and covariate analysis of pertuzumab, a HER2-targeted monoclonal antibody, and evaluation of a fixed, non-weight-based dose in patients with a variety of solid tumors","publication_year":2014,"publication_date":"2014-08-13","ids":{"openalex":"https://openalex.org/W2018147385","doi":"https://doi.org/10.1007/s00280-014-2560-3","mag":"2018147385","pmid":"https://pubmed.ncbi.nlm.nih.gov/25119184"},"language":"en","primary_location":{"id":"doi:10.1007/s00280-014-2560-3","doi":"https://doi.org/10.1007/s00280-014-2560-3","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s00280-014-2560-3","pdf_url":null,"source":{"id":"https://openalex.org/S117498271","display_name":"Cancer Chemotherapy and Pharmacology","issn_l":"0344-5704","issn":["0344-5704","1432-0843"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Chemotherapy and Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5101600119","display_name":"Amit Garg","orcid":"https://orcid.org/0000-0002-4553-9216","observed_orcids":["https://orcid.org/0000-0002-4553-9216"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Amit Garg","raw_affiliation_strings":["Clinical Pharmacology, MS 463a, Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA","GENENTECH,INC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Pharmacology, MS 463a, Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA","institution_ids":["https://openalex.org/I183934855"]},{"raw_affiliation_string":"GENENTECH,INC","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091201149","display_name":"Angelica Linnea Quartino","orcid":"https://orcid.org/0000-0003-0184-4670","observed_orcids":["https://orcid.org/0000-0003-0184-4670"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Angelica Quartino","raw_affiliation_strings":["Clinical Pharmacology, MS 463a, Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA","GENENTECH,INC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Pharmacology, MS 463a, Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA","institution_ids":["https://openalex.org/I183934855"]},{"raw_affiliation_string":"GENENTECH,INC","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100336882","display_name":"Jing Li","orcid":"https://orcid.org/0000-0002-1232-3056","observed_orcids":["https://orcid.org/0000-0002-1232-3056"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jing Li","raw_affiliation_strings":["Clinical Pharmacology, MS 463a, Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA","Genentech, Inc","MedImmune"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Pharmacology, MS 463a, Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA","institution_ids":["https://openalex.org/I183934855"]},{"raw_affiliation_string":"Genentech, Inc","institution_ids":["https://openalex.org/I183934855"]},{"raw_affiliation_string":"MedImmune","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100684966","display_name":"Jin Jin","orcid":"https://orcid.org/0000-0001-7887-5972","observed_orcids":["https://orcid.org/0000-0001-7887-5972"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jin Jin","raw_affiliation_strings":["Clinical Pharmacology, MS 463a, Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA","GENENTECH,INC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Pharmacology, MS 463a, Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA","institution_ids":["https://openalex.org/I183934855"]},{"raw_affiliation_string":"GENENTECH,INC","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050737404","display_name":"Daisuke Wada","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"D. Russell Wada","raw_affiliation_strings":["Quantitative Solutions Inc., Menlo Park, CA, 94025, USA","Quantitative Solutions Inc., Menlo Park, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Quantitative Solutions Inc., Menlo Park, CA, 94025, USA","institution_ids":[]},{"raw_affiliation_string":"Quantitative Solutions Inc., Menlo Park, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044150762","display_name":"Hanbin Li","orcid":"https://orcid.org/0009-0003-8798-9965","observed_orcids":["https://orcid.org/0009-0003-8798-9965"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hanbin Li","raw_affiliation_strings":["Quantitative Solutions Inc., Menlo Park, CA, 94025, USA","Quantitative Solutions Inc., Menlo Park, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Quantitative Solutions Inc., Menlo Park, CA, 94025, USA","institution_ids":[]},{"raw_affiliation_string":"Quantitative Solutions Inc., Menlo Park, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051629490","display_name":"Javier Cort\u00e9s","orcid":"https://orcid.org/0000-0001-7623-1583","observed_orcids":["https://orcid.org/0000-0001-7623-1583"]},"institutions":[{"id":"https://openalex.org/I4210127641","display_name":"Vall d'Hebron Hospital Universitari","ror":"https://ror.org/03ba28x55","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I157913058","https://openalex.org/I4210127641","https://openalex.org/I4210153292"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Javier Cort\u00e9s","raw_affiliation_strings":["Department of Oncology, Vall d\u2019Hebron University Hospital, Barcelona, Spain","Vall d\u2019Hebron University Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology, Vall d\u2019Hebron University Hospital, Barcelona, Spain","institution_ids":["https://openalex.org/I4210127641"]},{"raw_affiliation_string":"Vall d\u2019Hebron University Hospital","institution_ids":["https://openalex.org/I4210127641"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089319059","display_name":"Virginia A. McNally","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210113058","display_name":"Roche (United Kingdom)","ror":"https://ror.org/024tgbv41","country_code":"GB","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I4210113058"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Virginia McNally","raw_affiliation_strings":["F. Hoffmann-La Roche Ltd, 6 Falcon Way, Shire Park, Hexagon Place, Welwyn Garden City, AL7 1TW, Hertfordshire, UK","F. Hoffmann-La Roche Ltd, Welwyn Garden City, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"F. Hoffmann-La Roche Ltd, 6 Falcon Way, Shire Park, Hexagon Place, Welwyn Garden City, AL7 1TW, Hertfordshire, UK","institution_ids":["https://openalex.org/I4210113058"]},{"raw_affiliation_string":"F. Hoffmann-La Roche Ltd, Welwyn Garden City, UK","institution_ids":["https://openalex.org/I4210113058"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108568356","display_name":"Graham A. Ross","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210113058","display_name":"Roche (United Kingdom)","ror":"https://ror.org/024tgbv41","country_code":"GB","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I4210113058"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Graham Ross","raw_affiliation_strings":["F. Hoffmann-La Roche Ltd, 6 Falcon Way, Shire Park, Hexagon Place, Welwyn Garden City, AL7 1TW, Hertfordshire, UK","F. Hoffmann-La Roche Ltd, Welwyn Garden City, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"F. Hoffmann-La Roche Ltd, 6 Falcon Way, Shire Park, Hexagon Place, Welwyn Garden City, AL7 1TW, Hertfordshire, UK","institution_ids":["https://openalex.org/I4210113058"]},{"raw_affiliation_string":"F. Hoffmann-La Roche Ltd, Welwyn Garden City, UK","institution_ids":["https://openalex.org/I4210113058"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085856366","display_name":"Jennifer E. Visich","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jennifer Visich","raw_affiliation_strings":["Clinical Pharmacology, MS 463a, Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA","GENENTECH,INC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Pharmacology, MS 463a, Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA","institution_ids":["https://openalex.org/I183934855"]},{"raw_affiliation_string":"GENENTECH,INC","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5110076874","display_name":"Bert L. Lum","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bert Lum","raw_affiliation_strings":["Clinical Pharmacology, MS 463a, Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA","GENENTECH,INC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Pharmacology, MS 463a, Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA","institution_ids":["https://openalex.org/I183934855"]},{"raw_affiliation_string":"GENENTECH,INC","institution_ids":["https://openalex.org/I183934855"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5091201149"],"corresponding_institution_ids":["https://openalex.org/I183934855"],"apc_list":{"value":4390,"currency":"USD","value_usd":4390},"apc_paid":null,"fwci":2.2934,"has_fulltext":false,"cited_by_count":62,"citation_normalized_percentile":{"value":0.88897635,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":99},"biblio":{"volume":"74","issue":"4","first_page":"819","last_page":"829"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.7749000191688538,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.7749000191688538,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.08399999886751175,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.034299999475479126,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pertuzumab","display_name":"pertuzumab","score":1.0},{"id":"https://openalex.org/keywords/population-pharmacokinetics","display_name":"population pharmacokinetics","score":0.9399999976158142},{"id":"https://openalex.org/keywords/covariate-analysis","display_name":"covariate analysis","score":0.8790000081062317},{"id":"https://openalex.org/keywords/fixed-dose","display_name":"fixed dose","score":0.45899999141693115},{"id":"https://openalex.org/keywords/solid-tumors","display_name":"solid tumors","score":0.9419999718666077},{"id":"https://openalex.org/keywords/cleopatra-trial","display_name":"CLEOPATRA trial","score":0.7960000038146973},{"id":"https://openalex.org/keywords/serum-albumin","display_name":"serum albumin","score":0.7059999704360962},{"id":"https://openalex.org/keywords/lean-body-weight","display_name":"lean body weight","score":0.968999981880188},{"id":"https://openalex.org/keywords/elimination-clearance","display_name":"elimination clearance","score":0.7459999918937683},{"id":"https://openalex.org/keywords/exposure-simulation","display_name":"exposure simulation","score":0.4959999918937683},{"id":"https://openalex.org/keywords/dose-adjustment","display_name":"dose adjustment","score":0.6439999938011169}],"concepts":[{"id":"https://openalex.org/C2781164504","wikidata":"https://www.wikidata.org/wiki/Q1998021","display_name":"Pertuzumab","level":5,"score":0.9098140597343445},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.6224761009216309},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.5927671790122986},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.578889012336731},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5556914210319519},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4546835422515869},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.389700323343277},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.33161628246307373},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.1450694501399994},{"id":"https://openalex.org/C2779786085","wikidata":"https://www.wikidata.org/wiki/Q412616","display_name":"Trastuzumab","level":4,"score":0.09861519932746887},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D001835","descriptor_name":"Body Weight","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003661","descriptor_name":"Decision Support Techniques","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006207","descriptor_name":"Half-Life","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007262","descriptor_name":"Infusions, Intravenous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008657","descriptor_name":"Metabolic Clearance Rate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D012709","descriptor_name":"Serum Albumin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017711","descriptor_name":"Nonlinear Dynamics","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018734","descriptor_name":"Genes, erbB-2","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":true},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1007/s00280-014-2560-3","doi":"https://doi.org/10.1007/s00280-014-2560-3","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s00280-014-2560-3","pdf_url":null,"source":{"id":"https://openalex.org/S117498271","display_name":"Cancer Chemotherapy and Pharmacology","issn_l":"0344-5704","issn":["0344-5704","1432-0843"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Chemotherapy and Pharmacology","raw_type":"journal-article"},{"id":"pmid:25119184","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25119184","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer chemotherapy and pharmacology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320309432","display_name":"F. Hoffmann-La Roche","ror":"https://ror.org/00by1q217"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":41,"referenced_works":["https://openalex.org/W76525280","https://openalex.org/W1971267920","https://openalex.org/W2005475183","https://openalex.org/W2008166288","https://openalex.org/W2014457594","https://openalex.org/W2015186160","https://openalex.org/W2017264099","https://openalex.org/W2018956144","https://openalex.org/W2020721911","https://openalex.org/W2021838081","https://openalex.org/W2024651005","https://openalex.org/W2030437687","https://openalex.org/W2032198895","https://openalex.org/W2059050919","https://openalex.org/W2065039877","https://openalex.org/W2066996342","https://openalex.org/W2095861620","https://openalex.org/W2095879193","https://openalex.org/W2096111541","https://openalex.org/W2098797764","https://openalex.org/W2101299592","https://openalex.org/W2101349295","https://openalex.org/W2103755206","https://openalex.org/W2104239861","https://openalex.org/W2106215754","https://openalex.org/W2106339174","https://openalex.org/W2118160561","https://openalex.org/W2120661754","https://openalex.org/W2120946253","https://openalex.org/W2121915946","https://openalex.org/W2123591186","https://openalex.org/W2131082981","https://openalex.org/W2140765487","https://openalex.org/W2141821352","https://openalex.org/W2151425644","https://openalex.org/W2155567131","https://openalex.org/W2161708183","https://openalex.org/W2165003903","https://openalex.org/W2166199281","https://openalex.org/W2318066535","https://openalex.org/W2755747278"],"related_works":["https://openalex.org/W2017264099","https://openalex.org/W2061260182","https://openalex.org/W2247263719","https://openalex.org/W3167386266","https://openalex.org/W2685961074","https://openalex.org/W2302991267","https://openalex.org/W2908232818","https://openalex.org/W2518184903","https://openalex.org/W7143799354","https://openalex.org/W3096002369"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":8},{"year":2022,"cited_by_count":7},{"year":2021,"cited_by_count":6},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":11},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":7},{"year":2016,"cited_by_count":7},{"year":2013,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}